Amphastar制药2024年第四季度调整后每股收益为0.92美元,低于预期的0.94美元,销售额为1.865亿美元,未达到预期的1.888亿美元

财报速递02-28
Amphastar制药(NASDAQ:AMPH)报告其季度每股收益为0.92美元,低于分析师预期的0.94美元,相差2.13%。这是其上一年同期每股收益0.88美元的基础上增长了4.55%。该公司还报告季度销售额为1.865亿美元,低于分析师预期的1.888亿美元,相差1.22%。与去年同期1.78105亿美元的销售额相比,该季度销售额增长了4.71%。

以上内容来自Benzinga Earnings专栏,原文如下:

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.94 by 2.13 percent. This is a 4.55 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $186.500 million which missed the analyst consensus estimate of $188.810 million by 1.22 percent. This is a 4.71 percent increase over sales of $178.105 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法